GROWTH-HORMONE RESPONSE TO BROMOCRIPTINE IN PARKINSONISM
- 24 January 1976
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 307 (7952) , 194
- https://doi.org/10.1016/s0140-6736(76)91298-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Changes in Plasma Growth Hormone Levels in Normal and Acromegalic Subjects Following Administration of 2-Bromo-?-ErgocryptineJournal of Clinical Endocrinology & Metabolism, 1975
- Bromocriptine treatment of acromegaly.BMJ, 1975
- DECREASED PLASMA GROWTH HORMONE (GH) LEVELS IN ACROMEGALICS FOLLOWING CB 154(2-Br-α-ERGOCRYPTINE) ADMINISTRATION1Journal of Clinical Endocrinology & Metabolism, 1974
- Neural Regulation of Growth Hormone SecretionNew England Journal of Medicine, 1973
- Defective Release of Growth Hormone in Parkinsonism Improved by LevodopaNew England Journal of Medicine, 1973
- INHIBITORY EFFECT OF L-DOPA ON GH RELEASE IN ACROMEGALIC PATIENTS1Journal of Clinical Endocrinology & Metabolism, 1972
- Metabolic Responses to Acute and Chronicl-Dopa Administration in Patients with ParkinsonismNew England Journal of Medicine, 1972
- EFFECT OF l-DOPA ADMINISTRATION ON GROWTH HORMONE SECRETION IN NORMAL SUBJECTS AND PARKINSONIAN PATIENTSJournal of Endocrinology, 1972
- Endocrine Function and Glucose Metabolism in Patients with Parkinson's Disease and their Alteration byl-Dopa1Journal of Clinical Endocrinology & Metabolism, 1971
- Stimulation of Human-Growth-Hormone Secretion by L-DopaNew England Journal of Medicine, 1970